Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

65.16
+0.84001.31%
Post-market: 64.97-0.1900-0.29%19:55 EDT
Volume:4.00M
Turnover:259.53M
Market Cap:8.02B
PE:19.00
High:65.21
Open:64.32
Low:63.50
Close:64.32
Loading ...

Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference

PR Newswire
·
26 Feb

Analysts Conflicted on These Healthcare Names: Halozyme (HALO), Stoke Therapeutics (STOK) and Lantheus (LNTH)

TIPRANKS
·
23 Feb

Analysts Conflicted on These Healthcare Names: Halozyme (HALO), Walgreens Boots Alliance (WBA) and Axsome Therapeutics (AXSM)

TIPRANKS
·
23 Feb

Halozyme Therapeutics Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
20 Feb

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), GeneDx Holdings (WGS) and Bausch + Lomb Corporation (BLCO)

TIPRANKS
·
20 Feb

Halozyme Therapeutics: Record Earnings and Future Growth

TIPRANKS
·
20 Feb

Halozyme Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
19 Feb

Q4 2024 Halozyme Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
19 Feb

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), NeoGenomics (NEO) and Medtronic (MDT)

TIPRANKS
·
19 Feb

Halozyme price target raised to $72 from $70 at H.C. Wainwright

TIPRANKS
·
19 Feb

Halozyme Therapeutics Inc (HALO) Q4 2024 Earnings Call Highlights: Record Revenue and Strong ...

GuruFocus.com
·
19 Feb

JMP Securities Keeps Their Buy Rating on Halozyme (HALO)

TIPRANKS
·
19 Feb

Analysts Are Bullish on These Healthcare Stocks: Benitec Biopharma (BNTC), Halozyme (HALO)

TIPRANKS
·
19 Feb

Halozyme Therapeutics Achieves Record Revenue in 2024

TIPRANKS
·
19 Feb

Halozyme Therapeutics (HALO) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks
·
19 Feb

Halozyme Therapeutics (HALO) Q4 Earnings and Revenues Top Estimates

Zacks
·
19 Feb